The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

[2026 update] Confounding by indication, explained with a concrete example

This is a generated summary. It shows the 9 most-liked posts from a topic of 117, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
EF
erratum_fileTL3Regular25 Jan 2026#6

post #5 is right about the mechanism and I think understates the practical bit.

Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints.

27 likes 6mo
FF
f.fenwickTL3Regular29 Jan 2026#13

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

26 likes 6mo
IL
integrator_logTL3Regular4 Feb 2026#27

What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample size" alone is weak. "Small sample size for a rare outcome, so the confidence interval is wide" is stronger.

29 likes 6mo
IN
i.norgaardTL2 Moderator14 Feb 2026#53

Picking up post #50: that is the part I would want checked first.

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

28 likes 5mo
EM
endpoint_marginTL2Member19 Feb 2026#67

Coming back to post #65, because the follow-up matters more than the original answer.

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

27 likes 5mo
WM
w.moreauTL2 Moderator20 Feb 2026#71
compounding_ruth, post #52: Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for. Go to post

This follows post #68 rather than contradicting it.

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

30 likes in reply to #52 5mo
N
NLoughranTL3Regular23 Feb 2026#80
m.achebe, post #60: On post #56 — agreed on the reasoning, with one qualification. Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for. Go to post

I read post #78 twice before replying, because I had assumed the opposite.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

31 likes in reply to #60 5mo
TM
t.marchettiTL2 Moderator1 Mar 2026#98

Coming back to post #96, because the follow-up matters more than the original answer.

Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not how you use the evidence. The point estimate and the precision both matter.

30 likes 5mo
VT
vial_tableTL2Member2 Mar 2026#103
DOdendaal, post #23: Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had been repeating something I had not checked carefully enough. Go to post

Picking up post #100: that is the part I would want checked first.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

27 likes in reply to #23 5mo

Read the full topic (117 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
A well-designed study with a badly written abstract
Posting this under the heading it deserves: A well-designed study with a badly written abstract Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with LEADER ( N Engl J Med ,…
RCMICBMRPN+117 128 7.2k 14mo
Coming back to: Measurement error in a self-reported exposure
Measurement error in a self-reported exposure — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim I do not think it…
LARNOAKACD+23 27 49k 3mo
A structured critique template this community uses — a second dataset
On the subject in the title: A structured critique template this community uses — a second dataset Working notes rather than a conclusion. Session topic: SELECT ( N Engl J Med , 2023). Please read it before…
PRFLKBACAW+47 51 16k 15h
Coming back to: A critique that turned out to be unfair, retracted by its author
A critique that turned out to be unfair, retracted by its author — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not…
IAQLJB 2 1.3k 14mo
Immortal time bias in a claims-database study — one year on
Posting this under the heading it deserves: Immortal time bias in a claims-database study — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with SURMOUNT-1 (…
VMDMMGRPT+41 46 3.7k 22h

Related topics — sharing the tags observational data, disputed, risk of bias

TopicParticipantsRepliesViewsActivity
Journal club: SUSTAIN 6 and its retinopathy signal
On the subject in the title: Journal club: SUSTAIN 6 and its retinopathy signal Working notes rather than a conclusion. I have seen SELECT ( N Engl J Med , 2023) cited in support of a claim I do not think it…
LAMRZHOJI+110 122 46k 1d
The "under review" status pill and when a moderator applies it — a second dataset
The "under review" status pill and when a moderator applies it — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021)…
LVARMISLPM+50 54 1.4k 11mo
Secretagogues and glucose tolerance: the mechanistic concern — what changed since
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP 1 ( N Engl J Med , 2021)…
TLDKAIEF+2 6 31k 2mo
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold?
The question in the title: Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? I will give what I have already checked below so nobody repeats it. I have seen SURMOUNT-2 ( Lancet ,…
RONSPPSDOB+60 66 12k 16mo
Revisiting: Filing a first vendor report: a worked example
On the subject in the title: Revisiting: Filing a first vendor report: a worked example Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers…
RSMRCI 2 60k 11mo